Business
Announcement on Subsidiary's Approval from U.S. FDA for Production Site Transfer of Etoposide Injection
Announcement on Subsidiary's Approval from U.S. FDA for Production Site Transfer of Etoposide Injection
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Subsidiary's Approval from U.S. FDA for Production Site Transfer of Etoposide InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment